Ewelina Kulikowski

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

Biomedicines

Clinical epigenetics

Medicinal research reviews

Cardiovascular therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Dean Gilham, Sylwia Wasiak, Brooke D Rakai, Li Fu, Laura M Tsujikawa, Christopher D Sarsons, Agostina Carestia, Kenneth Lebioda, Jan O Johansson, Michael Sweeney, Kamyar Kalantar-Zadeh, Ewelina Kulikowski
Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment. Biomedicines 11 (6) (2023)
Dean Gilham, Sylwia Wasiak, Brooke D Rakai, Li Fu, Laura M Tsujikawa, Christopher D Sarsons, Agostina Carestia, Kenneth Lebioda, Jan O Johansson, Michael Sweeney, Kamyar Kalantar-Zadeh, Ewelina Kulikowski
Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment. Biomedicines 11 (6) (2023)
Christopher D Sarsons, Dean Gilham, Laura M Tsujikawa, Sylwia Wasiak, Li Fu, Brooke D Rakai, Stephanie C Stotz, Agostina Carestia, Michael Sweeney, Ewelina Kulikowski
Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells. Biomedicines 11 (10) (2023)
Sylwia Wasiak, Kim E Dzobo, Brooke D Rakai, Yannick Kaiser, Miranda Versloot, Mahnoush Bahjat, Stephanie C Stotz, Li Fu, Michael Sweeney, Jan O Johansson, Norman C W Wong, Erik S G Stroes, Jeffrey Kroon, Ewelina Kulikowski
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes. Clinical epigenetics 12 (1) (2020)
Sylwia Wasiak, Dean Gilham, Emily Daze, Laura M Tsujikawa, Christopher Halliday, Stephanie C Stotz, Brooke D Rakai, Li Fu, Ravi Jahagirdar, Michael Sweeney, Jan O Johansson, Norman C W Wong, Ewelina Kulikowski
Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease. Cardiovascular therapeutics 2020 (2020)
Ewelina Kulikowski, Brooke D Rakai, Norman C W Wong
Inhibitors of bromodomain and extra-terminal proteins for treating multiple human diseases. Medicinal research reviews 41 (1) (2020)
Laura M Tsujikawa, Li Fu, Shovon Das, Christopher Halliday, Brooke D Rakai, Stephanie C Stotz, Christopher D Sarsons, Dean Gilham, Emily Daze, Sylwia Wasiak, Deborah Studer, Kristina D Rinker, Michael Sweeney, Jan O Johansson, Norman C W Wong, Ewelina Kulikowski
Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism. Clinical epigenetics 11 (1) (2019)
Sylwia Wasiak, Dean Gilham, Laura M Tsujikawa, Christopher Halliday, Cyrus Calosing, Ravi Jahagirdar, Jan Johansson, Michael Sweeney, Norman C Wong, Ewelina Kulikowski
Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208). Journal of cardiovascular translational research 10 (4) (2017)

Ewelina Kulikowski.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ewelina Kulikowski